Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

D.P. Kontoyiannis

Department of Internal Medicine Specialties

Section of Infectious Diseases

The University of Texas M. D. Anderson Cancer Center

Houston

USA

[email]@*.mdacc.tmc.edu

Name/email consistency: high

[Claim this account]

Affiliations

Department of Internal Medicine Specialties, Section of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, USA. 1999 - 2001
The University of Texas M. D. Anderson Cancer Center, Section of Infectious Diseases, 1515 Holcombe Boulevard, Box 47, USA. 2000

References

Effect of fluconazole on agar invasion by Candida albicans. Kontoyiannis, D.P., Tarrand, J., Prince, R., Samonis, G., Rolston, K.V. J. Med. Microbiol. (2001) [Pubmed]
Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Kontoyiannis, D.P., Andersson, B.S., Lewis, R.E., Raad, I.I. Clin. Infect. Dis. (2001) [Pubmed]
Cryptococcosis in patients with cancer. Kontoyiannis, D.P., Peitsch, W.K., Reddy, B.T., Whimbey, E.E., Han, X.Y., Bodey, G.P., Rolston, K.V. Clin. Infect. Dis. (2001) [Pubmed]
Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis. Kontoyiannis, D.P., Bodey, G.P., Mantzoros, C.S. Mycoses (2001) [Pubmed]
Risk Factors for Candida tropicalis fungemia in patients with cancer. Kontoyiannis, D.P., Vaziri, I., Hanna, H.A., Boktour, M., Thornby, J., Hachem, R., Bodey, G.P., Raad, I.I. Clin. Infect. Dis. (2001) [Pubmed]
Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae. Kontoyiannis, D.P. Chemotherapy (2000) [Pubmed]
Cyclic AMP and fluconazole resistance in Saccharomyces cerevisiae. Kontoyiannis, D.P., Rupp, S. Antimicrob. Agents Chemother. (2000) [Pubmed]
Zygomycosis in the 1990s in a tertiary-care cancer center. Kontoyiannis, D.P., Wessel, V.C., Bodey, G.P., Rolston, K.V. Clin. Infect. Dis. (2000) [Pubmed]
Significance of aspergillemia in patients with cancer: a 10-year study. Kontoyiannis, D.P., Sumoza, D., Tarrand, J., Bodey, G.P., Storey, R., Raad, I.I. Clin. Infect. Dis. (2000) [Pubmed]
Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae. Kontoyiannis, D.P. J. Antimicrob. Chemother. (2000) [Pubmed]
Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae. Kontoyiannis, D.P. J. Antimicrob. Chemother. (2000) [Pubmed]
Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Kontoyiannis, D.P., Jacobson, K.L., Whimbey, E.E., Rolston, K.V., Raad, I.I. Clin. Infect. Dis. (2000) [Pubmed]
Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy. Kontoyiannis, D.P., Lewis, R.E., Sagar, N., May, G., Prince, R.A., Rolston, K.V. Antimicrob. Agents Chemother. (2000) [Pubmed]
Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae. Kontoyiannis, D.P., Sagar, N., Hirschi, K.D. Antimicrob. Agents Chemother. (1999) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.